Cargando…
Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that was traditionally thought to be closely related to genetic and environmental risk factors. Although treatment options for SLE with hormones, immunosuppressants, and biologic drugs are now available, the rates of clinical respons...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677698/ https://www.ncbi.nlm.nih.gov/pubmed/34925385 http://dx.doi.org/10.3389/fimmu.2021.799788 |
_version_ | 1784616194153644032 |
---|---|
author | Pan, Quanren Guo, Fengbiao Huang, Yanyan Li, Aifen Chen, Shuxian Chen, Jiaxuan Liu, Hua-feng Pan, Qingjun |
author_facet | Pan, Quanren Guo, Fengbiao Huang, Yanyan Li, Aifen Chen, Shuxian Chen, Jiaxuan Liu, Hua-feng Pan, Qingjun |
author_sort | Pan, Quanren |
collection | PubMed |
description | Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that was traditionally thought to be closely related to genetic and environmental risk factors. Although treatment options for SLE with hormones, immunosuppressants, and biologic drugs are now available, the rates of clinical response and functional remission of these drugs are still not satisfactory. Currently, emerging evidence suggests that gut microbiota dysbiosis may play crucial roles in the occurrence and development of SLE, and manipulation of targeting the gut microbiota holds great promises for the successful treatment of SLE. The possible mechanisms of gut microbiota dysbiosis in SLE have not yet been well identified to date, although they may include molecular mimicry, impaired intestinal barrier function and leaky gut, bacterial biofilms, intestinal specific pathogen infection, gender bias, intestinal epithelial cells autophagy, and extracellular vesicles and microRNAs. Potential therapies for modulating gut microbiota in SLE include oral antibiotic therapy, fecal microbiota transplantation, glucocorticoid therapy, regulation of intestinal epithelial cells autophagy, extracellular vesicle-derived miRNA therapy, mesenchymal stem cell therapy, and vaccination. This review summarizes novel insights into the mechanisms of microbiota dysbiosis in SLE and promising therapeutic strategies, which may help improve our understanding of the pathogenesis of SLE and provide novel therapies for SLE. |
format | Online Article Text |
id | pubmed-8677698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86776982021-12-18 Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies Pan, Quanren Guo, Fengbiao Huang, Yanyan Li, Aifen Chen, Shuxian Chen, Jiaxuan Liu, Hua-feng Pan, Qingjun Front Immunol Immunology Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that was traditionally thought to be closely related to genetic and environmental risk factors. Although treatment options for SLE with hormones, immunosuppressants, and biologic drugs are now available, the rates of clinical response and functional remission of these drugs are still not satisfactory. Currently, emerging evidence suggests that gut microbiota dysbiosis may play crucial roles in the occurrence and development of SLE, and manipulation of targeting the gut microbiota holds great promises for the successful treatment of SLE. The possible mechanisms of gut microbiota dysbiosis in SLE have not yet been well identified to date, although they may include molecular mimicry, impaired intestinal barrier function and leaky gut, bacterial biofilms, intestinal specific pathogen infection, gender bias, intestinal epithelial cells autophagy, and extracellular vesicles and microRNAs. Potential therapies for modulating gut microbiota in SLE include oral antibiotic therapy, fecal microbiota transplantation, glucocorticoid therapy, regulation of intestinal epithelial cells autophagy, extracellular vesicle-derived miRNA therapy, mesenchymal stem cell therapy, and vaccination. This review summarizes novel insights into the mechanisms of microbiota dysbiosis in SLE and promising therapeutic strategies, which may help improve our understanding of the pathogenesis of SLE and provide novel therapies for SLE. Frontiers Media S.A. 2021-12-03 /pmc/articles/PMC8677698/ /pubmed/34925385 http://dx.doi.org/10.3389/fimmu.2021.799788 Text en Copyright © 2021 Pan, Guo, Huang, Li, Chen, Chen, Liu and Pan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Pan, Quanren Guo, Fengbiao Huang, Yanyan Li, Aifen Chen, Shuxian Chen, Jiaxuan Liu, Hua-feng Pan, Qingjun Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies |
title | Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies |
title_full | Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies |
title_fullStr | Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies |
title_full_unstemmed | Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies |
title_short | Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies |
title_sort | gut microbiota dysbiosis in systemic lupus erythematosus: novel insights into mechanisms and promising therapeutic strategies |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677698/ https://www.ncbi.nlm.nih.gov/pubmed/34925385 http://dx.doi.org/10.3389/fimmu.2021.799788 |
work_keys_str_mv | AT panquanren gutmicrobiotadysbiosisinsystemiclupuserythematosusnovelinsightsintomechanismsandpromisingtherapeuticstrategies AT guofengbiao gutmicrobiotadysbiosisinsystemiclupuserythematosusnovelinsightsintomechanismsandpromisingtherapeuticstrategies AT huangyanyan gutmicrobiotadysbiosisinsystemiclupuserythematosusnovelinsightsintomechanismsandpromisingtherapeuticstrategies AT liaifen gutmicrobiotadysbiosisinsystemiclupuserythematosusnovelinsightsintomechanismsandpromisingtherapeuticstrategies AT chenshuxian gutmicrobiotadysbiosisinsystemiclupuserythematosusnovelinsightsintomechanismsandpromisingtherapeuticstrategies AT chenjiaxuan gutmicrobiotadysbiosisinsystemiclupuserythematosusnovelinsightsintomechanismsandpromisingtherapeuticstrategies AT liuhuafeng gutmicrobiotadysbiosisinsystemiclupuserythematosusnovelinsightsintomechanismsandpromisingtherapeuticstrategies AT panqingjun gutmicrobiotadysbiosisinsystemiclupuserythematosusnovelinsightsintomechanismsandpromisingtherapeuticstrategies |